Feeding Trial in the Obese Critical Care Population
Enteral Formula Tolerance in the Obese Critical Care Population
1 other identifier
observational
26
1 country
2
Brief Summary
This study will assess enteral feeding in an obese critically ill population with a higher protein whey based peptide formula.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2011
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 15, 2011
CompletedFirst Posted
Study publicly available on registry
May 20, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedJanuary 30, 2014
January 1, 2014
2.6 years
May 15, 2011
January 29, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
time to feeding goal achievement
on all participants
up to 5 days
Secondary Outcomes (4)
gastrointestinal measures assessment
daily for up to 11 days
percent of nutrition goal met
up to 5 days
serum biochemical markers assessment
daily for up to 11 days
assessment of frequency and nature of adverse events
daily for up to 11 days
Study Arms (1)
critically ill obese adults
Age ≥ 18 years, body mass index (BMI) ≥ 30, in intensive care unit (ICU) requiring tube feeding ≥ 3 days
Interventions
Complete feeding of study enteral formula, route and regime prescribed by the physician.
Eligibility Criteria
critically ill obese adults
You may qualify if:
- Age ≥ 18 years
- Surgical or Medical intensive care unit (ICU) patient
- Body mass index (BMI) ≥ 30
You may not qualify if:
- pregnant or lactating
- unable to access gastrointestinal (GI) tract for feeding via tube
- other contraindication to tube feeding
- admitted with burns
- severe head trauma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Kentucky
Lexington, Kentucky, 40536, United States
University of Louisville
Louisville, Kentucky, 40202, United States
Biospecimen
serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2011
First Posted
May 20, 2011
Study Start
May 1, 2011
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
January 30, 2014
Record last verified: 2014-01